Results 21 to 30 of about 38,749 (246)

To compare the level of cystatin C in type 2 diabetes mellitus with obesity

Indian Journal of Endocrinology and Metabolism, 2020
Background: Cystatin C is a non-glycosylated basic protein that is produced and secreted at a constant rate by all nucleated cells. Cystatin C is a more reliable marker than the serum creatinine because it is less affected by external factors such as ...
Chahat Jhatta, Jashan Girdhar, Sumeet Gupta, Inderjeet Verma   +3 more
doaj   +1 more source

Longitudinal study of Cystatin C in healthy term newborns

Clinics, 2011
OBJECTIVE: The purpose of this study was to determine the levels of Cystatin C in healthy term newborns in the first month of life. INTRODUCTION: Cystatin C may be a suitable marker for determining the glomerular filtration rate because it is not ...
Ana Carolina de Albuquerque Cavalcanti Ferreira Novo, Lilian dos Santos Rodrigues Sadeck, Thelma Suely Okay, Clea Rodrigues Leone   +3 more
doaj   +1 more source

Cystatin C and Aging Success [PDF]

Archives of Internal Medicine, 2008
To our knowledge, the effect of kidney function on successful aging has not been examined.We evaluated the relationship between cystatin C and aging success during a 6-year follow-up in the Cardiovascular Health Study, a community-based cohort of older adults (aged >or= 65 years). Successful aging was defined as remaining free of cardiovascular disease,
Mark J, Sarnak, Ronit, Katz, Linda F, Fried, David, Siscovick, Brian, Kestenbaum, Stephen, Seliger, Dena, Rifkin, Russell, Tracy, Anne B, Newman, Michael G, Shlipak   +9 more
openaire   +2 more sources

Cystatin C: A Primer for Pharmacists [PDF]

Pharmacy, 2020
Pharmacists are at the forefront of dosing and monitoring medications eliminated by or toxic to the kidney. To evaluate the effectiveness and safety of these medications, accurate measurement of kidney function is paramount. The mainstay of kidney assessment for drug dosing and monitoring is serum creatinine (SCr)-based estimation equations.
Hilary R. Teaford, Jason N. Barreto, Kathryn J. Vollmer, Andrew D. Rule, Erin F. Barreto   +4 more
openaire   +3 more sources

Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration

Haematologica, 2009
Background Renal impairment is a common complication of multiple myeloma. Cystatin-C is considered an accurate marker of glomerular filtration rate in several renal disorders.
Evangelos Terpos, Eirini Katodritou, Evangelos Tsiftsakis, Efstathios Kastritis, Dimitrios Christoulas, Anastasia Pouli, Eurydiki Michalis, Evgenia Verrou, Konstantinos Anargyrou, Konstantinos Tsionos, Meletios A. Dimopoulos, Konstantinos Zervas   +11 more
doaj   +1 more source

Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease. [PDF]

PLoS ONE, 2018
Cystatin C is a cysteine protease inhibitor that is produced by nearly all human cells. The serum level of cystatin C is a stronger predictor of the renal outcome and the risk of cardiovascular events than the creatinine level.
Ayu Ogawa-Akiyama, Hitoshi Sugiyama, Masashi Kitagawa, Keiko Tanaka, Akifumi Onishi, Toshio Yamanari, Hiroshi Morinaga, Haruhito Adam Uchida, Kazufumi Nakamura, Hiroshi Ito, Jun Wada   +10 more
doaj   +1 more source

Cystatin C is Associated With Plaque Phenotype and Plaque Burden

Kidney & Blood Pressure Research, 2016
Background/Aims: The relationship between carotid artery plaque burden, phenotype and serum cystatin C at normal and impaired renal function is still unclear. Methods: Demographic characteristics, carotid ultrasonography and other relevant information of
Yufeng Wen, Dan Xia, Yanchun Wang, Huiping Zhang, Haibo Li, Gholam Ali, Yongqing Gao, Jian Li, Wenjie Sun, Linlin Li   +9 more
doaj   +1 more source

Maternal Cystatin C Serum is Higher in Women with Severe Preeclampsia

Indonesian Journal of Obstetrics and Gynecology, 2014
Objective: To determine the comparison between maternal cystatin C serum in severe preeclampsia and normal pregnancy. Method: This was an observational study with cross sectional analytic approach. The subjects are sixty women with severe preeclampsia
Kurnia M. Isasari, Wim T Pangemanan, Iskandar Zulqarnain, Kemas Rahadiyanto   +3 more
doaj   +1 more source

Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. [PDF]

PLoS ONE, 2010
Amyotrophic lateral sclerosis (ALS) is a fatal neurologic disease characterized by progressive motor neuron degeneration. Clinical disease management is hindered by both a lengthy diagnostic process and the absence of effective treatments.
Meghan E Wilson, Imene Boumaza, David Lacomis, Robert Bowser   +3 more
doaj   +1 more source

Cystatin C predicts cognitive decline in multiple system atrophy: A 1-year prospective cohort study

Frontiers in Aging Neuroscience, 2022
BackgroundAccumulating evidence has suggested that cystatin C is associated with cognitive impairment in patients with neurodegenerative diseases. However, the association between cystatin C and cognitive decline in patients with multiple system atrophy (
Lingyu Zhang, Lingyu Zhang, Ruicen Li, Yanbing Hou, Bei Cao, Qianqian Wei, Ruwei Ou, Kuncheng Liu, Junyu Lin, Tianmi Yang, Yi Xiao, Wenxia Huang, Huifang Shang   +12 more
doaj   +1 more source